医学
协商一致会议
糖尿病
梅德林
重症监护医学
内科学
内分泌学
法学
政治学
作者
Jiwei Shen,Cheng Ji,Xuedong Fang,Bo Yang,Tian Zhang,Zhengcai Li,H. Li,Zhiyi Liu,Jun Tang,Chuanwen Liao,Jiao Lu,Yang Xuan,Xinguo Zhang
出处
期刊:World Journal of Diabetes
[Baishideng Publishing Group Co (World Journal of Diabetes)]
日期:2024-10-16
卷期号:15 (11): 2182-2188
标识
DOI:10.4239/wjd.v15.i11.2182
摘要
Diabetes mellitus (DM) is a group of diseases characterized by high blood glucose caused by insufficient absolute or relative secretion of insulin. Once diagnosed, patients need long-term treatment with hypoglycemic drugs. Currently, the existing first-line hypoglycemic drugs do not provide effective treatment for DM and its complications. In the past, the first generation and the second generation of weight loss surgery, such as gastric bypass and sleeve gastric surgery, had strict body mass index requirements. Moreover, post-surgery, patients are prone to fluctuating hypoglycemia, gastroesophageal reflux, and dumping syndrome. Hence, the curative effect of this type of surgery was compromised to a certain extent. Jejunoileostomy is a third-generation surgery for patients with DM, which has been shown to improve glucose and lipid metabolism, without changing the original gas-trointestinal tract structure. Different from previous weight loss surgeries, jejunoileostomy has been clinically observed to delay the development of DM-related complications. Additionally, the postoperative complications are mild and do not affect the patient’s quality of life. Based on our clinical observations from multi-center large samples, our team developed a consensus on the operative period and perioperative management of jejunoi-leostomy as a reference for clinical researchers.
科研通智能强力驱动
Strongly Powered by AbleSci AI